State of Tennessee, Department of Treasury’s BioMarin Pharmaceuticals BMRN Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.67M	Sell	81,548 -9,713	-11%	-$532K	0.01%	621
2026 Q1	$5.16M	Hold	91,261	–	–	0.02%	560
2025 Q4	$5.16M	Sell	91,261 -3,814	-4%	-$208K	0.02%	566
2025 Q3	$5.15M	Buy	95,075 +4,375	+5%	+$250K	0.02%	553
2025 Q2	$4.99M	Buy	90,700 +6,427	+8%	+$378K	0.02%	552
2025 Q1	$5.96M	Buy	84,273 +3,871	+5%	+$260K	0.02%	474
2024 Q4	$5.28M	Sell	80,402 -2,269	-3%	-$152K	0.02%	535
2024 Q3	$5.81M	Buy	82,671 +8,794	+12%	+$735K	0.02%	500
2024 Q2	$6.08M	Buy	+73,877	New	+$6.15M	0.02%	481
2016 Q4	–	Sell	-18,371	Closed	-$1.7M	–	1517
2016 Q3	$1.7M	Buy	+18,371	New	+$1.73M	0.01%	857
2015 Q2	–	Sell	-100,784	Closed	-$12.6M	–	1424
2015 Q1	$12.6M	Buy	+100,784	New	+$10.7M	0.07%	297

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State of Tennessee, Department of Treasury's BMRN Position: Q2 2026 in Review

State of Tennessee, Department of Treasury reduced its BioMarin Pharmaceuticals (BMRN) stake by 11% in Q2 2026, selling an estimated $532K and leaving 81,548 shares worth $4.67M. The position accounts for 0.01% of the portfolio, ranked #621.

State of Tennessee, Department of Treasury first reported a position in BMRN in Q1 2015 and has held it in 11 quarters since. The position peaked at $12.6M in Q1 2015. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

State of Tennessee, Department of Treasury held 81,548 shares of BioMarin Pharmaceuticals worth $4.67M as of Q2 2026.
State of Tennessee, Department of Treasury sold 9,713 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $532K.
BioMarin Pharmaceuticals made up 0.01% of State of Tennessee, Department of Treasury's portfolio in Q2 2026, its #621 holding.
State of Tennessee, Department of Treasury first reported a position in BioMarin Pharmaceuticals in Q1 2015 and has held it in 11 quarters since.
State of Tennessee, Department of Treasury's BioMarin Pharmaceuticals position peaked at $12.6M in Q1 2015.
564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2026, filed 14 Aug 2026.